Medicare Enrolled
Dr. Sandeep Kodityal, MD
Hematology & Oncology · Shenandoah, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kodityal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kodityal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kodityal
Dr. Sandeep Kodityal is a hematology & oncology specialist in Shenandoah, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kodityal performed 50,021 Medicare services across 1,119 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kodityal received a total of $256,787 from 82 pharmaceutical and/or device companies across 1010 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kodityal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 19% volume in TX
$256,787 industry payments
Medicare Practice Summary
Medicare Utilization ↗50,021
Medicare services
Top 19% in TX for hematology & oncology
1,119
Unique beneficiaries
$6
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~2,633 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron sucrose injection (Venofer) An injection of iron sucrose used to replenish iron levels in the body. |
31,800 | $0 | $1 |
| Darbepoetin injection (Aranesp) for anemia An injection of darbepoetin alfa used for non-end-stage renal disease purposes. |
8,919 | $2 | $8 |
| Contrast dye for imaging (iodine-based) A contrast agent containing 300-399 mg/ml of iodine used to enhance imaging studies. It is administered per milliliter to improve the visibility of internal structures. |
4,200 | $0 | $0 |
| Flow cytometry, additional marker An additional marker is tested during a flow cytometry procedure to analyze DNA or cells. This step adds specific data points to the initial analysis. |
1,991 | $19 | $63 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
832 | $91 | $348 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
684 | $0 | $0 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
276 | $22 | $82 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
217 | $10 | $39 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
204 | $47 | $179 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
202 | $98 | $374 |
| Flow cytometry DNA or cell analysis, first marker A laboratory test that uses a laser to analyze cells or DNA by detecting a specific marker on the cell surface or within the cell. |
89 | $58 | $193 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
80 | $118 | $451 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
77 | $18 | $73 |
| Nuclear medicine scan from skull base to mid-thigh with CT A nuclear medicine imaging study covering the area from the base of the skull to the middle of the thighs, performed alongside a CT scan. |
68 | $1,135 | $5,267 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 63 | $110 | $295 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
62 | $77 | $345 |
| CT scan of chest, without contrast A computed tomography scan of the chest area that uses X-rays to create detailed images without the use of contrast dye. |
41 | $44 | $329 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
34 | $91 | $283 |
| CT scan of chest with contrast A computed tomography scan of the chest using a contrast dye to enhance the visibility of internal structures. |
33 | $60 | $440 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
32 | $133 | $504 |
| CT scan of abdomen and pelvis, without contrast A computed tomography scan that creates detailed images of the abdominal and pelvic organs. The procedure is performed without the use of intravenous contrast dye. |
28 | $74 | $452 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
28 | $61 | $246 |
| CT scan of abdomen and pelvis with contrast A CT scan that uses dye to create detailed images of the abdomen and pelvis. This imaging test helps doctors examine internal organs and structures in these areas. |
24 | $168 | $809 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
21 | $18 | $62 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $137 | $480 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
92.0% medium
6.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$256,787
Total received (2018-2024)
Avg $36,684/year across 7 years
Top 2% in TX for hematology & oncology
82
Companies
1,010
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$238,301 (92.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$12,637 (4.9%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$5,850 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$37,281
2023
$50,525
2022
$33,277
2021
$23,219
2020
$22,349
2019
$43,986
2018
$46,150
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$102,781
Lilly USA, LLC
$89,643
Takeda Pharmaceuticals U.S.A., Inc.
$30,746
Mirati Therapeutics, Inc.
$7,715
Gilead Sciences, Inc.
$6,023
Karyopharm Therapeutics Inc.
$3,026
E.R. Squibb & Sons, L.L.C.
$2,751
PFIZER INC.
$1,861
Amgen Inc.
$1,476
Foundation Medicine, Inc.
$1,094
Astellas Pharma US Inc
$956
Novartis Pharmaceuticals Corporation
$797
Celgene Corporation
$776
Janssen Biotech, Inc.
$740
Daiichi Sankyo Inc.
$423
Seagen Inc.
$406
Merck Sharp & Dohme Corporation
$396
Alexion Pharmaceuticals, Inc.
$371
Incyte Corporation
$296
GENZYME CORPORATION
$237
BeiGene USA, Inc.
$209
GlaxoSmithKline, LLC.
$205
PharmaEssentia USA Corporation
$196
Merck Sharp & Dohme LLC
$194
Genentech USA, Inc.
$186
Adaptive Biotechnologies Corporation
$182
ASD SPECIALTY HEALTHCARE, LLC
$182
Pharmacyclics LLC, An AbbVie Company
$171
Boehringer Ingelheim Pharmaceuticals, Inc.
$157
Rigel Pharmaceuticals, Inc.
$143
ABBVIE INC.
$139
TESARO, Inc.
$136
Deciphera Pharmaceuticals Inc.
$112
Janssen Scientific Affairs, LLC
$94
Verastem, Inc.
$94
Eisai Inc.
$88
SANOFI-AVENTIS U.S. LLC
$87
Janssen Pharmaceuticals, Inc
$87
EISAI INC.
$81
MorphoSys, US Inc.
$68
Bayer HealthCare Pharmaceuticals Inc.
$67
SOBI, INC
$66
Clovis Oncology, Inc.
$64
ARRAY BIOPHARMA INC
$63
CTI BioPharma Corp.
$63
EMD Serono, Inc.
$61
Kite Pharma, Inc.
$59
PUMA BIOTECHNOLOGY, INC.
$56
Exelixis Inc.
$54
Teva Pharmaceuticals USA, Inc.
$50
Dendreon Pharmaceuticals LLC
$46
ADC Therapeutics America, Inc.
$45
Regeneron Healthcare Solutions, Inc.
$45
Puma Biotechnology, Inc.
$44
Bayer Healthcare Pharmaceuticals Inc.
$44
Ipsen Biopharmaceuticals, Inc
$42
Blueprint Medicines Corporation
$42
Seattle Genetics, Inc.
$35
Dova Pharmaceuticals
$33
Sobi, Inc
$30
Shionogi Inc
$27
TG THERAPEUTICS, INC.
$26
Myovant Sciences Inc.
$26
JAZZ PHARMACEUTICALS INC.
$26
BOSTON SCIENTIFIC CORPORATION
$25
Immunocore Limited
$25
MEDIVATION FIELD SOLUTIONS LLC
$25
Alnylam Pharmaceuticals Inc.
$23
Stemline Therapeutics Inc.
$23
SpringWorks Therapeutics, Inc.
$22
TerSera Therapeutics LLC
$22
AVEO Pharmaceuticals, Inc.
$22
Jazz Pharmaceuticals Inc.
$20
Kyowa Kirin, Inc.
$20
Spectrum Pharmaceuticals Inc.
$20
TAIHO ONCOLOGY, INC.
$19
Epizyme, Inc.,
$18
Mylan Institutional Inc.
$15
Heron Therapeutics, Inc.
$14
Taiho Oncology, Inc.
$14
Pharmacosmos Therapeutics Inc.
$12
Sirtex Medical Inc
$9
Top 3 companies account for 86.9% of total payments
Associated products mentioned in payments ›
ADAKVEO · ADCETRIS · AFINITOR · ALIMTA · ALUNBRIG · AUGTYRO · AVYCAZ · AYVAKIT · Abraxane · Alecensa · Avastin · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · CABLIVI · CALQUENCE · CHANTIX · CINVANTI · COSELA · CYRAMZA · Cabometyx · Columvi · Copiktra · DARZALEX · DOPTELET · Doptelet · ELIQUIS · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FOUNDATIONONE LIQUID · Fetroja · Folotyn · Fulphila · GILOTRIF · HYQVIA · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INFLECTRA · INJECTAFER · INLYTA · Imbruvica · JAKAFI · JEVTANA · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · MEKINIST · MONJUVI · MVASI · Monoferric · NERLYNX · NINLARO · Neulasta · Nexavar · Nplate · Nubeqa · OGSIVEO · OPDIVO · OPDUALAG · ORGOVYX · OXLUMO · Orserdu · PADCEV · PIQRAY · POTELIGEO · PROMACTA · PROVENGE · Padcev · Pomalyst · Prolia · QINLOCK · REBLOZYL · RETEVMO · Rezlidhia · Rubraca · SARCLISA · SCEMBLIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SUTENT · TABRECTA · TAGRISSO · TAZVERIK · TECENTRIQ · TUKYSA · TUMOR LYSIS SYNDROME - DISEASE · Tavalisse · Tecentriq · TheraSphere Y90 Glass Microspheres 10 GBq · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONJO · VYXEOS · Vectibix · Venclexta · Vitrakvi · Vonjo · Vyloy · XALKORI · XARELTO · XGEVA · XPOVIO · XTANDI · Xofigo · Xospata · Xtandi · ZEJULA · Zoladex · Zydelig · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (93%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in hematology & oncology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for hematology & oncology in TX.
Equivalent to $513 per 100 Medicare services performed
Geographic Context
Hematology & oncology specialists within 10 mi
27
Per 100K population
4.1
County median income
$97,266
Nearest hospital
ST LUKE'S THE WOODLANDS HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kodityal is a mixed practice specialist, with above-average Medicare volume (top 19% in TX), with speaking/promotional industry engagement in the top 2% of TX peers, with 19 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kodityal experienced with iron sucrose injection (venofer)?
Based on Medicare claims data, Dr. Kodityal performed 31,800 iron sucrose injection (venofer) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kodityal receive payments from pharmaceutical companies?
Yes. Dr. Kodityal received a total of $256,787 from 82 companies across 1,010 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kodityal's costs compare to other hematology & oncology specialists in Shenandoah?
Dr. Kodityal's average Medicare payment per service is $6. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kodityal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Shenandoah
Browse hematology & oncology specialists in Shenandoah ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in TX
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in TX
Which TX hematology & oncology specialists receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology